Corrigendum to “CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells” [Biomed. Pharmacother. 71 (2015) 84–90] - 11/11/23
Doi : 10.1016/j.biopha.2023.115662
Ji Shi a, b, Longlong Meng a, Ming-Zhong Sun c, ⁎ 
, Chunmei Guo c, Xujuan Sun a, c, Qiuyue Lin a, Shuqing Liu a, d, ⁎
, Chunmei Guo c, Xujuan Sun a, c, Qiuyue Lin a, Shuqing Liu a, d, ⁎ a Department of Biochemistry, Dalian Medical University, Dalian 116044, China
b Department of Pathology, The First Affiliated Hospital of China Medical University, Anshan Hospital, Liaoning 114012, China
c Department of Biotechnology, Dalian Medical University, Dalian 116044, China
d Provincial Key Laboratory of Cell and Molecular Biology, Dalian Medical University, Dalian 116044, China
⁎Corresponding author.⁎⁎Corresponding author at: Department of Biochemistry, Dalian Medical University, Dalian 116044, China.Department of Biochemistry, Dalian Medical UniversityDalian116044China
Le texte complet de cet article est disponible en PDF.
© 2023
Elsevier Masson SAS. Tous droits réservés.
Vol 168
Article 115662- décembre 2023 Retour au numéro
Article précédent
- Modulatory mechanisms of cannabinoids as a window of hope to patients with sleep-related cardiometabolic risk
- Miguel Meira e Cruz
- Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
- Clément Delage, Maeva Palayer, Bruno Etain, Monique Hagenimana, Nathan Blaise, Julie Smati, Margot Chouchana, Vanessa Bloch, Valérie C. Besson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?